Lux Capital positions itself as a contrarian investor supporting "rebels at the frontiers of science and technology." The firm closed a $1.5 billion fund to invest in deep technology ventures "at the outermost edges of what is possible."
A key part of their thesis is investing "before it's obvious"—backing founders turning sci-fi into sci-fact. In 2025, Lux launched Lux Labs, a $100 million initiative supporting academic research at risk due to federal funding cuts.
Lux is heavily invested in AI companies including Physical Intelligence, Hugging Face, and Together AI.
Defense innovation through companies like Anduril's "loyal wingman" drones and Saildrone's subsea surveillance systems.
Varda's space-manufactured drugs and Eikon Therapeutics' AI-driven drug discovery represent the kind of breakthrough bets Lux makes.
In 2025, Lux launched Lux Labs, a $100 million initiative supporting academic research at risk due to federal funding cuts.
Among Lux's top prospects to go public are weapons manufacturer Anduril, data platform Databricks, and payments provider Ramp.
Source: Lux Capital
Last updated: January 1, 2025